-
1دورية أكاديمية
المؤلفون: Kumar S; Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology (MIET), NH-58, Delhi-Roorkee Highway, Meerut, 250005, Uttar Pradesh, India., Taumar D; Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology (MIET), NH-58, Delhi-Roorkee Highway, Meerut, 250005, Uttar Pradesh, India., Gaikwad S; Division of Virology, ICMR-National AIDS Research Institute, Ministry of Health & Family Welfare, Plot No. 73, 'G' Block, MIDC, Bhosari, Pune, 411026, Maharashtra, India., More A; Division of Virology, ICMR-National AIDS Research Institute, Ministry of Health & Family Welfare, Plot No. 73, 'G' Block, MIDC, Bhosari, Pune, 411026, Maharashtra, India., Nema V; Division of Virology, ICMR-National AIDS Research Institute, Ministry of Health & Family Welfare, Plot No. 73, 'G' Block, MIDC, Bhosari, Pune, 411026, Maharashtra, India., Mukherjee A; Division of Virology, ICMR-National AIDS Research Institute, Ministry of Health & Family Welfare, Plot No. 73, 'G' Block, MIDC, Bhosari, Pune, 411026, Maharashtra, India. amukherjee@nariindia.org.
المصدر: Drug delivery and translational research [Drug Deliv Transl Res] 2024 Jul; Vol. 14 (7), pp. 1888-1908. Date of Electronic Publication: 2023 Dec 31.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE
مواضيع طبية MeSH: Atazanavir Sulfate*/pharmacokinetics , Atazanavir Sulfate*/administration & dosage , HIV Infections*/drug therapy , HIV-1*/drug effects, Humans ; Animals ; Emulsions ; Drug Delivery Systems ; Oils, Volatile/administration & dosage ; Oils, Volatile/chemistry ; Oils, Volatile/pharmacokinetics ; Oils, Volatile/pharmacology ; Male ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/pharmacokinetics ; HIV Protease Inhibitors/therapeutic use ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/pharmacokinetics ; Anti-HIV Agents/chemistry ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Nanoparticle Drug Delivery System/chemistry
-
2دورية أكاديمية
المؤلفون: Gausi K; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Mugerwa H; Joint Clinical Research Centre, Research Department, Kampala, Uganda., Siccardi M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Montanha MC; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Lamorde M; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., D'Avolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wilkins E; North Manchester General Hospital, HIV Research Unit, Manchester, United Kingdom., De Nicolò A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Khoo S; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Kityo C; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Waitt C; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.
المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1246-1255.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Atazanavir Sulfate*/pharmacokinetics , Atazanavir Sulfate*/administration & dosage , Atazanavir Sulfate*/adverse effects , Atazanavir Sulfate*/therapeutic use , Rifampin*/pharmacokinetics , Rifampin*/administration & dosage , Rifampin*/adverse effects , Ritonavir*/pharmacokinetics , Ritonavir*/administration & dosage , Ritonavir*/adverse effects , HIV Infections*/drug therapy , Drug Interactions*, Humans ; Male ; Female ; Adult ; Middle Aged ; HIV Protease Inhibitors/pharmacokinetics ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/adverse effects ; HIV Protease Inhibitors/therapeutic use ; Uganda ; Anti-HIV Agents/pharmacokinetics ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/administration & dosage ; Drug Therapy, Combination ; Drug Administration Schedule
-
3دورية أكاديمية
المؤلفون: Shah D; Center for Post-Graduate Studies & Research in Pharmaceutical Sciences, Shri GH Patel Pharmacy building, Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390002, India., Rawat J; Center for Post-Graduate Studies & Research in Pharmaceutical Sciences, Shri GH Patel Pharmacy building, Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390002, India., Thakkar H; Center for Post-Graduate Studies & Research in Pharmaceutical Sciences, Shri GH Patel Pharmacy building, Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390002, India.
المصدر: Therapeutic delivery [Ther Deliv] 2023 Apr; Vol. 14 (4), pp. 269-280. Date of Electronic Publication: 2023 Jun 21.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101538870 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-6008 (Electronic) Linking ISSN: 20415990 NLM ISO Abbreviation: Ther Deliv Subsets: MEDLINE
مواضيع طبية MeSH: Atazanavir Sulfate*, Biological Availability ; Solubility ; Drug Liberation ; Solvents/chemistry ; Tablets/chemistry ; Administration, Oral
-
4دورية أكاديمية
المؤلفون: Ludna Duarte M; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: mairaludna@gmail.com., Mikaelle Brandão Silva A; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil., Wellithom Viturino da Silva J; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil., Pereira Santana D; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: davi.santana@nudfac.com.br., Victor de Castro W; Graduate Program in Pharmaceutical Sciences, Federal University of São João del-Rei, Av. Sebastião Gonçalves Coelho 400, Chanadour, Divinópolis, Minas Gerais, CEP 35501-296, Brazil. Electronic address: whocely@ufsj.edu.br., Cláudio Arraes de Alencar L; Department of Tropical Medicine, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil., César Galindo Bedor D; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: danilo.bedor@nudfac.com.br., Bastos Leal L; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: leila.leal@nudfac.com.br.
المصدر: Clinical biochemistry [Clin Biochem] 2024 May; Vol. 127-128, pp. 110765. Date of Electronic Publication: 2024 Apr 20.
نوع المنشور: Journal Article; Validation Study
بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0133660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2933 (Electronic) Linking ISSN: 00099120 NLM ISO Abbreviation: Clin Biochem Subsets: MEDLINE
مواضيع طبية MeSH: Benzoxazines*/blood , Benzoxazines*/pharmacokinetics , Benzoxazines*/therapeutic use , Cyclopropanes*/blood , Alkynes* , Tandem Mass Spectrometry*/methods , Drug Monitoring*/methods , Dried Blood Spot Testing*/methods , HIV Infections*/drug therapy , HIV Infections*/blood, Humans ; Female ; Pregnancy ; Atazanavir Sulfate/blood ; Atazanavir Sulfate/therapeutic use ; Atazanavir Sulfate/pharmacokinetics ; Ritonavir/blood ; Ritonavir/therapeutic use ; Chromatography, Liquid/methods ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/blood ; Raltegravir Potassium/blood ; Raltegravir Potassium/therapeutic use ; Anti-HIV Agents/blood ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacokinetics ; Liquid Chromatography-Mass Spectrometry
-
5دورية أكاديمية
المؤلفون: Mulato A; Department of Virology, Gilead Sciences, Foster City, California, USA., Lansdon E; Department of Structural Biology and Chemistry, Gilead Sciences, Foster City, California, USA., Aoyama R; Department of Drug Metabolism, Gilead Sciences, Foster City, California, USA., Voigt J; Department of Structural Biology and Chemistry, Gilead Sciences, Foster City, California, USA., Lee M; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Liclican A; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Lee G; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Singer E; Department of Virology, Gilead Sciences, Foster City, California, USA., Stafford B; Department of Drug Metabolism, Gilead Sciences, Foster City, California, USA., Gong R; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Murray B; Department of Drug Metabolism, Gilead Sciences, Foster City, California, USA., Chan J; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Lee J; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Xu Y; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Ahmadyar S; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Gonzalez A; Department of Medicinal Chemistry, Gilead Sciences, Foster City, California, USA., Cho A; Department of Medicinal Chemistry, Gilead Sciences, Foster City, California, USA., Stepan GJ; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Schmitz U; Department of Structural Biology and Chemistry, Gilead Sciences, Foster City, California, USA., Schultz B; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Marchand B; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Brumshtein B; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Wang R; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Yu H; Department of Discovery Sciences and Technology, Gilead Sciences, Foster City, California, USA., Cihlar T; Department of Virology, Gilead Sciences, Foster City, California, USA., Xu L; Department of Medicinal Chemistry, Gilead Sciences, Foster City, California, USA., Yant SR; Department of Virology, Gilead Sciences, Foster City, California, USA.
المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Apr 03; Vol. 68 (4), pp. e0137323. Date of Electronic Publication: 2024 Feb 21.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
مواضيع طبية MeSH: HIV Protease Inhibitors*/pharmacology , HIV Protease Inhibitors*/therapeutic use , HIV-1*/genetics , HIV Infections*/drug therapy, Humans ; Darunavir/pharmacology ; Darunavir/therapeutic use ; Atazanavir Sulfate/pharmacology ; Atazanavir Sulfate/therapeutic use ; Drug Resistance, Viral ; Anti-Retroviral Agents/therapeutic use ; HIV Protease/genetics ; HIV Protease/metabolism
-
6دورية أكاديمية
المؤلفون: Panza F; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy., Saladini F; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Bartolini N; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Gianmarino F; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Montagnani F; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy., Spagnuolo V; Department of Infectious Diseases, IRCSS San Raffaele Scientific Institute, Milan, Italy., Tumbarello M; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy., Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Castagna A; Department of Infectious Diseases, IRCSS San Raffaele Scientific Institute, Milan, Italy., Zazzi M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Fabbiani M; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
المصدر: The new microbiologica [New Microbiol] 2024 May; Vol. 47 (1), pp. 116-122.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Edizioni Internazionali srl Country of Publication: Italy NLM ID: 9516291 Publication Model: Print Cited Medium: Print ISSN: 1121-7138 (Print) Linking ISSN: 11217138 NLM ISO Abbreviation: New Microbiol Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV Infections*/virology , HIV-1*/drug effects , HIV-1*/genetics , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/pharmacology , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/administration & dosage , Drug Resistance, Multiple, Viral*/genetics , Genotype* , Piperazines*/therapeutic use , Cobicistat*/therapeutic use , Cobicistat*/administration & dosage, Humans ; Male ; Middle Aged ; Atazanavir Sulfate/therapeutic use ; Rilpivirine/therapeutic use ; Pyridones/therapeutic use ; Oxazines/therapeutic use ; Microbial Sensitivity Tests ; Phenotype
-
7دورية أكاديمية
المؤلفون: Sethi S; Pharmaceutics Division, Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, 147002, India., Rana V; Pharmaceutics Division, Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, 147002, India. vikas_pbi@rediffmail.com.
المصدر: Drug delivery and translational research [Drug Deliv Transl Res] 2023 Jan; Vol. 13 (1), pp. 339-355. Date of Electronic Publication: 2022 Aug 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE
مواضيع طبية MeSH: Atazanavir Sulfate*/pharmacology , Histamine H2 Antagonists*/pharmacology, Animals ; Rats ; Biological Products/pharmacology ; Rats, Wistar
-
8دورية أكاديمية
المؤلفون: Elgammal Y; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, 1410 Prices Fork Rd, Blacksburg, VA, 24061, USA.; Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061, USA., Salama EA; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, 1410 Prices Fork Rd, Blacksburg, VA, 24061, USA.; Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061, USA., Seleem MN; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, 1410 Prices Fork Rd, Blacksburg, VA, 24061, USA. seleem@vt.edu.; Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061, USA. seleem@vt.edu.
المصدر: Scientific reports [Sci Rep] 2024 Jan 18; Vol. 14 (1), pp. 1571. Date of Electronic Publication: 2024 Jan 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
مواضيع طبية MeSH: HIV Protease Inhibitors*/pharmacology , Candidiasis, Invasive*/drug therapy , Triazoles*, Animals ; Mice ; Antifungal Agents/pharmacology ; Antifungal Agents/therapeutic use ; Atazanavir Sulfate/pharmacology ; Atazanavir Sulfate/therapeutic use ; Saquinavir/pharmacology ; Candida auris ; Candida ; Microbial Sensitivity Tests
-
9دورية أكاديمية
المؤلفون: Shamu T; Newlands Clinic, Harare, Zimbabwe.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Graduate School of Health Sciences, University of Bern, Bern, Switzerland., Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Mudzviti T; Newlands Clinic, Harare, Zimbabwe.; Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe., Chimbetete C; Newlands Clinic, Harare, Zimbabwe., Manasa J; Innovation Hub, University of Zimbabwe, Harare, Zimbabwe., Anderegg N; Newlands Clinic, Harare, Zimbabwe.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.
المصدر: PloS one [PLoS One] 2024 Feb 23; Vol. 19 (2), pp. e0293162. Date of Electronic Publication: 2024 Feb 23 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
مواضيع طبية MeSH: Anti-HIV Agents*/therapeutic use , HIV Infections*/drug therapy , Piperazines* , Pyridones* , Alkynes* , Oxazines* , Heterocyclic Compounds, 3-Ring* , Cyclopropanes*, Humans ; Female ; Male ; Atazanavir Sulfate/therapeutic use ; Longitudinal Studies ; Zimbabwe ; Bayes Theorem ; Benzoxazines/therapeutic use ; Viral Load
-
10دورية أكاديمية
المؤلفون: Shamu T; Newlands Clinic, Harare, Zimbabwe.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Graduate School of Health Sciences, University of Bern, Bern, Switzerland., Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Mudzviti T; Newlands Clinic, Harare, Zimbabwe.; Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe., Chimbetete C; Newlands Clinic, Harare, Zimbabwe., Manasa J; Innovation Hub, University of Zimbabwe, Harare, Zimbabwe., Anderegg N; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.
المصدر: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26216.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN: 1758-2652 (Electronic) Linking ISSN: 17582652 NLM ISO Abbreviation: J Int AIDS Soc Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV Infections*/epidemiology , Hypertension* , Anti-HIV Agents*/adverse effects , Piperazines* , Pyridones* , Alkynes* , Oxazines* , Cyclopropanes*, Adult ; Male ; Humans ; Female ; Longitudinal Studies ; Atazanavir Sulfate/adverse effects ; Blood Pressure ; Zimbabwe/epidemiology ; Bayes Theorem ; Benzoxazines/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Weight Gain ; Body Weight